EVJ podcast spotlights key equine medicine papers from BEVA 2026
Bottom line
EVJ and BEVA have released a new October 2026 Newshour medicine podcast built around recent equine research, with Nicola Menzies-Gow summarizing notable papers from the past year as part of the BEVA Congress 2026 educational program. The podcast sits alongside Wiley’s BEVA Newshour 2026 virtual issue, which groups the papers highlighted in the Congress session across medicine, surgery, sports medicine, and qualitative research. In the medicine section, topics include radiofrequency catheter ablation for recurrent atrial fibrillation in horses, a smart textile ECG monitor for racehorses during high-speed exercise, and work on using ertugliflozin to blunt post-triamcinolone hyperinsulinemia. BEVA is also offering Congress 2026 sessions on demand, extending the reach of the material beyond in-person attendees. (evj.podbean.com)
Why it matters: For equine veterinarians, this isn’t just another Congress recap. The Newshour format packages clinically relevant literature into a fast CPD update, and the paper selection points to where practice is moving: more advanced equine cardiology, closer scrutiny of metabolic risk around corticosteroid use, and better field-friendly monitoring tools. One of the featured studies, for example, found ertugliflozin lowered glucose and insulin changes after intra-articular triamcinolone in eight metabolically normal geldings, while the atrial fibrillation ablation paper showed the promise, and current limits, of highly specialized referral-level intervention, with two of seven horses still in sinus rhythm at 14 and 47 months. (beva.onlinelibrary.wiley.com)
What to watch: Expect follow-up discussion to center on which of these findings are ready for broader clinical uptake, and which remain best viewed as early, referral-setting evidence. (evj.podbean.com)
Equine Veterinary Journal has published its October 2026 BEVA Congress Newshour medicine podcast, with Nicola Menzies-Gow reviewing recent papers highlighted during the BEVA Congress 2026 NewsHour session. The episode is part of EVJ’s broader Congress-linked education package, which now includes a dedicated BEVA Newshour 2026 virtual issue and on-demand access to the Congress lecture program. (evj.podbean.com)
That matters because the Newshour sessions have become a curated shortcut for busy clinicians who want the signal, not the noise, from the year’s equine literature. Wiley’s virtual issue shows the medicine content wasn’t presented in isolation: it sits alongside surgery, sports medicine and orthopaedics, and qualitative and social science, reflecting BEVA’s effort to connect research updates with day-to-day practice and professional decision-making. The 2026 Congress itself was positioned as a flagship forum for the equine veterinary community, and the lecture recordings package means those updates now have a longer shelf life. (beva.onlinelibrary.wiley.com)
The medicine lineup in the virtual issue gives a good sense of the themes Menzies-Gow was likely drawing from. Featured papers include a July 24, 2026, EVJ article on radiofrequency catheter ablation for recurrent, persistent naturally occurring atrial fibrillation; a June 25, 2026, open-access study validating a smart textile electrocardiographic monitoring device in racehorses during high-speed exercise; and a February 1, 2026, paper reporting that ertugliflozin mitigated the hyperinsulinemic response to intra-articular triamcinolone acetonide. Other medicine papers in the same collection address equine influenza surveillance, a vaccine study involving Streptococcus zooepidemicus respiratory disease in ponies, survival in strangulating small intestinal lesions, and prognosis in larval cyathostominosis. (beva.onlinelibrary.wiley.com)
A closer look at two of those studies helps explain the clinical interest. In the ertugliflozin paper, investigators at the University of Kentucky used a prospective, controlled crossover design in eight metabolically normal geldings and found significantly lower insulin and glucose measures after intra-articular triamcinolone when horses were treated with ertugliflozin. The authors concluded that the strategy may help reduce hyperinsulinemia, and potentially laminitis risk, but stressed that further work is needed in horses with insulin dysregulation, the group most likely to matter in practice. (beva.onlinelibrary.wiley.com)
The atrial fibrillation study, from Ghent University and collaborators in Belgium, shows both innovation and caution. Researchers reviewed seven horses with persistent, recurrent atrial fibrillation treated using three-dimensional electro-anatomical mapping and radiofrequency catheter ablation. Arrhythmogenic substrates were identified in the caudal vena cava and pulmonary veins, but recurrence remained common: five of seven horses relapsed, and only two remained in sinus rhythm at follow-up of 14 and 47 months. The authors explicitly said the study does not demonstrate benefit and that more research is needed to improve trigger identification and ablation technique. (beva.onlinelibrary.wiley.com)
Industry reaction, at least so far, has been more educational than promotional. EVJ has already spun the ablation paper into a separate “EVJ Snippets” podcast, suggesting the journal sees these studies as discussion starters for clinicians rather than settled standards of care. BEVA, meanwhile, is continuing to monetize and distribute the Congress educational package through on-demand access, reinforcing how conference-linked journal content is becoming part of the profession’s year-round learning infrastructure. (evj.podbean.com)
Why it matters: For veterinary professionals, the real value here is curation. Equine clinicians are being asked to keep pace with increasingly specialized cardiology, wearable diagnostics, metabolic medicine, and evidence that may be promising but still preliminary. A Newshour-style review from a known expert can help practices decide what belongs in immediate case discussions, what should inform referral conversations with pet parents, and what still sits firmly in the “watch this space” category. The featured papers also underline a broader workforce and education point: staying current now means navigating not just new findings, but different levels of evidence, accessibility, and readiness for use in general practice versus referral settings. (evj.podbean.com)
What to watch: The next step is whether EVJ, BEVA, or the featured authors publish follow-on commentary, guidelines, or additional studies that move these medicine topics from interesting Congress discussion to clearer clinical recommendations, especially around insulin-dysregulated horses and advanced arrhythmia management. (beva.onlinelibrary.wiley.com)